The global D-Lactate-Free Probiotics Market size is expected to reach USD 84.92 Billion in 2032. The D-lactate-free probiotics market is growing rapidly.
As per FMI Analysts, the global D-lactate-free probiotics market is estimated to be valued at USD 39.70 Billion in 2022 and is projected to increase at a CAGR of 7.9% in the forecast period from 2022 to 2032.
| Report Attribute | Details |
|---|---|
| D-Lactate Free Probiotics Market Estimated Base Year Value (2021) | USD 36.79 Billion |
| D-Lactate Free Probiotics Market Expected Market Value (2022) | USD 39.70 Billion |
| D-Lactate Free Probiotics Market Anticipated Forecast Value (2032) | USD 84.92 Billion |
| D-Lactate Free Probiotics Market Projected Growth Rate (2022 to 2032) | 7.9% CAGR |
Various nutritional and health benefits are gaining traction for functional foods and dietary supplements. Probiotics are experiencing rapid growth due to increasing consumer health concerns and awareness about the benefits of bacteria in the body.
Sedentary and busy lifestyles, coupled with unhealthy eating habits, are contributing to digestive disturbances and other health issues.
D-lactate-free probiotics manufacturers, therefore, focus a great deal on short bowel syndrome and autism to increase sales. This, in turn, drives growth in the d-lactate-free probiotics market.
There is a risk of developing D-lactate encephalopathy in people who suffer from short bowel syndrome, and d-lactate-free probiotics are generally recommended for people with autism, small bacterial overgrowths, and histamine-related issues.
As these patients become more aware of the health impact of d-lactate-producing stains, the adoption of d-lactate-free probiotics is on the rise.
Probiotics' numerous benefits to humans, such as improved mental health, balanced gut microflora, and the treatment and prevention of digestive disorders, the probiotics industry is soaring and will further propel growth in the d-lactate-free probiotics market.
A growing awareness of the potential health impacts of D-Lactate will enable stakeholders in the D-lactate-free probiotics market to gain opportunities.
With the probiotics market experiencing a growing level of competition, manufacturers are increasingly developing customized probiotics, such as lactate-free products, to meet the growing needs of individual customers.
Companies are utilizing technology and unique strategies to create unparalleled, superior probiotics that support healthy digestion.
DuPont Nutrition & Health, a key player in the d-lactate-free market, has completed the construction of a new probiotic fermentation facility at its Rochester facility. This is a major investment that increases the company's capacity by nearly 70% and enhances its leadership status in clinically documented probiotics, contributing to the growing demand for d-lactate-free probiotics.
In Phase III clinical trial, Hansen, a global bioscience company, has partnered with Prota Therapeutics, a leader in developing oral immunotherapies to prevent food allergies. Before any treatment for peanut allergy is released, LGG® will be evaluated, the best-documented probiotic strain worldwide.
The D-lactate-free probiotics market has received a lot of traction in the industry.
Stakeholders can benefit from this growing awareness of D-lactate's potential health impact through D-lactate-free probiotic products.
The use of d-lactate-free probiotics is generally recommended for individuals who are diagnosed with autism, small bacterial overgrowth, or histamine issues. As patients receive more and more information about the health dangers of d-lactate and the health effects of d-lactate-free probiotics, more and more people are switching to d-lactate-free probiotics.
Increasing consumption of probiotic products, especially among those with mental health issues, balanced gut microflora, and treatments & prevention of certain digestive disorders, is augmenting growth in the probiotics market. A proliferating probiotic sector will further underpin the growth of d-lactate-free probiotics.
Dietary supplements and functional foods are gaining increasing traction due to their wide range of nutrition and health benefits. Probiotics market growth has been attributed to the rapid rise of consumer health concerns and awareness about the benefits of good microbes and gut health. Increased sedentary lifestyles, coupled with poor eating habits, are contributing to more digestive issues among the general population.
In response, many D-lactate-free probiotics manufacturers are focusing their efforts on short bowel syndrome, autism, and neurodevelopmental disorders in an attempt to grow sales of D-lactate-free probiotics. This is driving growth in the d-lactate-free probiotics market.
Creating opportunities for stakeholders in the D-lactate-free probiotics industry by raising awareness of the health risks caused by D-lactate
A proliferating probiotics industry will further sustain gains in the d-lactate-free probiotics market, with its multitude of health benefits, such as improved mental health, balanced gut microflora, and treatment and prevention of certain digestive disorders.
Over the forecast period, North America is expected to experience significant growth. Strong investment from the pharmaceutical and food and beverage industries is expected to contribute to the expansion of the d-lactate-free probiotics regional market.
The regional players are investing in D-lactate-free probiotics to create new products to cater to different age groups and genders. Such factors are expected to expedite the growth of the international d-lactate-free probiotics market over the forecast period.
Stakeholders are working on the development of temperature-stable bacteria that can be consumed without refrigeration or ice for a couple of weeks without losing any potency.
Furthermore, they are striving to make ingredients without gluten, sugar, soy, casein, dairy, yeast, flavors, preservatives, FOS, inulin, artificial colors, or any genetically modified ingredients.
Some of the leading companies operating in the global D-lactate-free probiotics market include DowDuPont, Custom Probiotics, Greentech, Organic 3, Inc., UAS Laboratories, BioGaia AB, Danone, Sabinsa, Novozymes, Chr. Hansen, Yakult Honsha, Synbiotech, Nestlé, and Biosearch Life.
To meet the burgeoning demands of customers, manufacturers are creating custom probiotics, such as d-lactate-free products.
To take advantage of the growing competition in the probiotics market, companies are embracing unique strategies and integrating technology to develop unmatched, superior probiotics that promote physical and mental wellness, generating lucrative opportunities for the growth of the d-lactate-free probiotics market.
With its recent USD 100 million investment in a new probiotic fermentation plant, DuPont Nutrition & Health strives to extend its probiotics capacity by nearly 70%, as well as improve its leadership in clinically documented probiotics. With the new fermenting unit, the company intends to expand its probiotics capacity by nearly 70% and increase its leadership in probiotics research.
The Hansen Company, a global bioscience company, has formed a partnership with Prota Therapeutics, which develops oral immunotherapies to treat food allergies. Together, the two companies will study the best documented probiotic strain worldwide, LGG®, in Phase III clinical trial to develop alternatives to peanut allergies.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 7.9% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million, Volume in Kilotons, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | Ingredient Type, Function, Application, Distribution Channel |
| Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, Russia, Poland, Australia, New Zealand, China, India, Japan, South Korea, Thailand, Malaysia, Vietnam, Indonesia, GCC Countrie, Turkey, South Africa, North Africa |
| Key Companies Profiled | DowDuPont; Custom Probiotics; Greentech; Organic 3, Inc.; UAS Laboratories; BioGaia AB; Danone; Sabinsa; Novozymes; Chr. Hansen,; Yakult Honsha,; Synbiotech, Nestlé; Biosearch Life |
| Customization | Available Upon Request |
The global D-lactate-free probiotics market is set to exceed USD 84.92 Billion in 2032.
The USA is projected to lead the D-lactate-free probiotics market in the forecast period.
DowDuPont, Custom Probiotics, Greentech, Organic 3, Inc., and others are some of the renowned companies in the D-lactate-free probiotics market.
Explore Similar Insights
D-Lactate Free Probiotics Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
